Event details

July 11, 2023 at 8:00 AM EDT

American Medical Association Releases Language of First New Current Procedural Terminology Code for Psychedelic Therapies

COMPASS will hold a webinar on the new code for investors, analysts and media on Tuesday, July 11, 2023, at 8:00 am EDT (1:00 pm BST). The webinar will feature:
  • Dr. Geoffrey Grammer, Chief Medical Officer at Greenbrook NeuroHealth Centers
  • Dr. Marketa Wills, Chief Medical Officer at Johns Hopkins HealthCare
  • Kabir Nath, Chief Executive Officer at COMPASS
  • Dr. Steve Levine, Senior Vice President of Patient Access and Medical Affairs at COMPASS.

The one-hour moderated discussion will focus on the impact of the new code for healthcare delivery professionals and payers, and the role of the code in establishing commercial models for psychedelic treatment if these therapies receive regulatory approval.

Please register in advance here to access the webinar and obtain a local or toll-free phone number and personal pin. A live audio webcast of the webinar will be accessible from the “Events” page of the Investors section of the COMPASS website. The replay of the webcast will be accessible for 30 days following the event. For more information, please visit ir.compasspathways.com.

Back to previous page
Print page Email alerts RSS feeds
You are now leaving COMPASS Pathways’ website.

COMPASS does not control and is not responsible for the content on the website you are about to visit. COMPASS is providing this link as a convenience, and this link does not imply COMPASS endorsement of any material on the website you are about to visit. Do you wish to continue?

No Yes